Abstract:Ferroptosis is a non-apoptotic form of regulated cell death characterized by iron-dependent lipid peroxidation. It can be triggered by various mechanisms, including the glutathione peroxidase 4 (GPX4)-glutathione (GSH) axis, iron metabolism, lipid metabolism, the GTP cyclohydrolase 1 (GCH1)-tetrahydrobiopterin (BH4) pathway, and the ferroptosis suppressor protein 1 (FSP1)-coenzyme Q10 axis. The redox balance is disrupted when ferroptosis occurs in cells, which is fatal to cancer cells. Additionally, some tumor-associated genes are involved in ferroptosis. Hence, targeting ferroptosis might be an effective strategy for treating cancer. Several small-molecule compounds exhibit anti-tumor effects through ferroptosis, including sorafenib and altretamine, which induce ferroptosis by inhibiting System-Xc and GPX4 respectively, but many problems, such as poor druggability, still exist. Some studies have shown that many traditional Chinese medicine (TCM) induce ferroptosis by inhibiting GPX4, solute carrier family 7 member 11 (SLC7A11), and nuclear factor (erythroid-derived 2)-like 2 (Nrf2), or by increasing the expression of Acyl-CoA synthetase long-chain family member 4 (ACSL4), transferrin (TF), and transferrin receptor 1 (TFR1). These changes can lead to the lysosomal degradation of ferritin, accumulation of iron, lipid peroxidation and the production of reactive oxygen species (ROS), which in turn can promote anti-tumor activities or synergistic effects with chemotherapeutic drugs. In this study, we elucidated the underlying mechanisms of ferroptosis, and the anti-tumor pharmacology of TCM targeting ferroptosis including prescriptions, Chinese herbs, extracts, and natural compounds. Our findings might act as valuable reference for research on anti-tumor drugs targeting ferroptosis, especially those drugs developed from TCM.

System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy

System Xc−: a key regulatory target of ferroptosis in cancer

Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis

Advances in ferroptosis of cancer therapy

Recent Progress of Glutathione Peroxidase 4 Inhibitors in Cancer Therapy

GPX4, ferroptosis, and diseases

Research progress on GPX4 targeted compounds

Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling

Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges

The Mechanism of Ferroptosis and Applications in Tumor Treatment

FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications

ZX703: A Small-Molecule Degrader of GPX4 Inducing Ferroptosis in Human Cancer Cells

Advancing the frontiers of colorectal cancer treatment: harnessing ferroptosis regulation

Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases

Role of oxidative stress‐induced ferroptosis in cancer therapy

A review on the research progress of traditional Chinese medicine with anti-cancer effect targeting ferroptosis

Ferroptosis-related oxaliplatin resistance in multiple cancers: Potential roles and therapeutic Implications

A Class of Disulfide Compounds Suppresses Ferroptosis by Stabilizing GPX4

Targeting lipid metabolism for ferroptotic cancer therapy

Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance